Literature DB >> 11773464

Prognostic indicators of IgA nephropathy in the Chinese--clinical and pathological perspectives.

Philip Kam Tao Li1, Kelvin Kai Leung Ho, Cheuk Chun Szeto, LyMee Yu, Fernand Mac-Moune Lai.   

Abstract

BACKGROUND: IgA nephropathy is the most common primary glomerulonephritis in the world. Up to 30% of patients can progress to end-stage renal disease (ESRD) in 10 years.
METHODS: We studied 168 Chinese patients with IgA nephropathy followed for an average of 7.4 years in our hospital and tried to identify the clinical and pathological data that were associated with the prognosis of the disease. Clinical features at the time of renal biopsy were reviewed. Severity of histological involvement was scored semi-quantitatively as grade 1-3.
RESULTS: There was a female preponderance in our cohort of patients (male:female ratio 1:1.5). The average age at biopsy was 32.9+/-10.0 years. Forty-seven of the 168 patients (28.0%) were hypertensive and 47 of 136 patients (34.6%) had a family history of hypertension. A high histological grade of IgA nephropathy was associated with hypertension at presentation, family history of hypertension, a higher serum creatinine, total cholesterol and 24-h urine protein excretion, and a lower serum albumin level. During the follow-up period, four patients died and another 24 progressed to ESRD. The renal survival was 92.0% at 1 year, 87.5% at 5 years and 81.8% at 10 years. With univariate analysis, hypertension at presentation, family history of hypertension, renal impairment at presentation (plasma creatinine >120 micromol/l), high cholesterol, proteinuria >1 g/day and high histological grading were associated with poor prognosis. With multivariate analysis, hypertension at presentation, family history of hypertension, renal impairment at presentation, proteinuria >1 g/day and histological grading were independent predictors of renal survival. The relative risks of renal failure for patients were 9.60 (95% confidence interval 4.02-22.92) with hypertension, 1.56 (1.16-2.02) with a family history of hypertension, 15.38 (6.40-36.93) with renal impairment and 5.93 (3.07-11.46) with every increase of one histological grade. Male patients did not show a more adverse outcome compared with females.
CONCLUSIONS: Our results suggest that renal biopsy remains useful, even in clinically trivial disease, because of its distinct value in prognosis and risk stratification. The long-term prognosis of IgA nephropathy in Chinese patients is guarded. The prognostic importance of family history of hypertension has not been widely recognized and requires further study.

Entities:  

Mesh:

Year:  2002        PMID: 11773464     DOI: 10.1093/ndt/17.1.64

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  48 in total

1.  Development and validation of a prediction rule using the Oxford classification in IgA nephropathy.

Authors:  Shigeru Tanaka; Toshiharu Ninomiya; Ritsuko Katafuchi; Kosuke Masutani; Akihiro Tsuchimoto; Hideko Noguchi; Hideki Hirakata; Kazuhiko Tsuruya; Takanari Kitazono
Journal:  Clin J Am Soc Nephrol       Date:  2013-10-31       Impact factor: 8.237

2.  IgA nephropathy: is a new approach beyond proteinuria necessary?

Authors:  Eduardo Gutiérrez
Journal:  Pediatr Nephrol       Date:  2019-02-18       Impact factor: 3.714

3.  Comparison between steroid pulse therapy alone and in combination with tonsillectomy for IgA nephropathy.

Authors:  Ayami Ochi; Takahito Moriyama; Takashi Takei; Keiko Uchida; Kosaku Nitta
Journal:  Int Urol Nephrol       Date:  2012-07-26       Impact factor: 2.370

Review 4.  MicroRNAs in IgA nephropathy.

Authors:  Cheuk-Chun Szeto; Philip K-T Li
Journal:  Nat Rev Nephrol       Date:  2014-04-08       Impact factor: 28.314

Review 5.  Novel biomarkers in glomerular disease.

Authors:  Yasar Caliskan; Krzysztof Kiryluk
Journal:  Adv Chronic Kidney Dis       Date:  2014-03       Impact factor: 3.620

6.  Expression of prorenin receptor in renal biopsies from patients with IgA nephropathy.

Authors:  Nagisa Miyazaki; Ichijiro Murata; Genzou Takemura; Hideshi Okada; Hiromitsu Kanamori; Jun Matsumoto-Miyazaki; Gakuro Yoshida; Kumiko Izumi; Hitomi Kashi; Kaori Niimi; Ayuko Nishiwaki; Tatsuhiko Miyazaki; Michiya Ohno; Hiroshige Ohashi; Fumiaki Suzuki; Shinya Minatoguchi
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

7.  Risk factors for persistent proteinuria after a 2-year combination therapy for severe childhood IgA nephropathy.

Authors:  Koichi Kamei; Koichi Nakanishi; Shuichi Ito; Kenji Ishikura; Hiroshi Hataya; Masataka Honda; Kandai Nozu; Kazumoto Iijima; Yuko Shima; Norishige Yoshikawa
Journal:  Pediatr Nephrol       Date:  2014-12-10       Impact factor: 3.714

8.  A molecular signature of proteinuria in glomerulonephritis.

Authors:  Heather N Reich; David Tritchler; Daniel C Cattran; Andrew M Herzenberg; Felix Eichinger; Anissa Boucherot; Anna Henger; Celine C Berthier; Viji Nair; Clemens D Cohen; James W Scholey; Matthias Kretzler
Journal:  PLoS One       Date:  2010-10-18       Impact factor: 3.240

9.  Association of C4d deposition with clinical outcomes in IgA nephropathy.

Authors:  Mario Espinosa; Rosa Ortega; Marina Sánchez; Alfons Segarra; Maria Teresa Salcedo; Fayna González; Rafael Camacho; Miguel Angel Valdivia; Rocio Cabrera; Katia López; Fernando Pinedo; Eduardo Gutierrez; Alfonso Valera; Miryam Leon; Maria Angeles Cobo; Rosa Rodriguez; Jose Ballarín; Yolanda Arce; Beatriz García; María Dolores Muñoz; Manuel Praga
Journal:  Clin J Am Soc Nephrol       Date:  2014-02-27       Impact factor: 8.237

10.  Potential of renal pathology on refining syndrome typing of Chinese medicine in IgA nephropathy.

Authors:  Jian-Jun Li; Xiang-Mei Chen; Ri-Bao Wei
Journal:  Chin J Integr Med       Date:  2012-12-03       Impact factor: 1.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.